Audited Results of Bafna Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	150.62	145.86	152.47	115.35	85.14
Manufacturing Expenses	19.44	20.98	18.88	12.95	10.40
Personnel Expenses	21.92	21.03	19.03	15.87	14.50
Selling Expenses	0.81	0.35	0.47	0	0.14
Administrative Expenses	9.46	10.24	14.95	7.17	7.71
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	134.67	134.68	141.35	99.63	73.65
Operating Profit	15.95	11.18	11.11	15.72	11.49
Other Recurring Income	4.76	2.74	3.52	3.27	2.10
Adjusted PBDIT	20.70	13.92	14.63	18.99	13.59
Financial Expenses	3.66	2.73	2.29	2.04	0.79
Depreciation	6.07	4.89	5	5.33	5.49
Other Write offs	0	0	0	0	0
Adjusted PBT	10.97	6.30	7.35	11.62	7.31
Tax Charges	-0.13	0	0	0.28	0
Adjusted PAT	11.10	6.30	7.35	11.34	7.31
Non Recurring Items	0	-2.33	0.04	0.15	-2.16
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	11.10	4.15	7.35	11.34	5.15
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	-32.01	-43.13	-47.10	-54.48	-66.01

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article